01/03/2015 - 17:01 Infliximab caused liver injury in 8.3% of treated patients in a prospective study, exceeding rates for other tumor necrosis factor-alpha antagonists, ... More » Visit websiteField of Interest: Gastroentero...Categories: CME-candidateFPN || JournalsFPN || NewsIMN || JournalsIMN || JournalIMN || NewsIMN || DermatologyNews Feed: Internal Medicine News - Gastroenterology